|
Diabetes, Vol 29, Issue 11 919-925, Copyright © 1980 by American Diabetes Association
Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects
EG Offenbacher and FX Pi-Sunyer
Twenty-four volunteers, mean age 78, including eight mildly
non-insulin-dependent diabetics, were randomly allocated to one of two
groups and were fed (daily for 8 wk) 9 g of either chromium-rich brewers'
yeast (experimental) or chromium-poor torula yeast (control). Before and
after yeast supplementation, the serum glucose and insulin response to 100
g oral glucose was measured at 30 min intervals for 2 h. Fasting serum
cholesterol, total lipids, and triglycerides were also determined. In the
total experimental group (normals + diabetics) and in both the diabetic and
nondiabetic experimental subgroups, glucose tolerance improved
significantly and insulin output decreased after supplementation.
Cholesterol and total lipids fell significantly after supplementation in
the total experimental group. The cholesterol decrease was particularly
marked in hypercholesterolemic subjects (cholesterol > 300 mg/dl). In
the control group, no significant change in glucose tolerance, insulin,
triglycerides, or total lipids was found. Cholesterol was significantly
lowered in the nondiabetic but not in the diabetic group. Thus,
chromium-rich brewers' yeast improved glucose tolerance and total lipids in
elderly subjects, while chromium-poor torula yeast did not. An improvement
in insulin sensitivity also occurred with brewers' yeast supplementation.
This supports the thesis that elderly people may have a low level of
chromium and that an effective source for chromium repletion, such as
brewers' yeast, may improve their carbohydrate tolerance and total lipids.
The improvement in serum cholesterol in some control subjects, as well as
in the total experimental group, also suggests the presence of a
hypocholesterolemic factor other than chromium in both brewers' and torula
yeast.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. M. Balk, A. Tatsioni, A. H. Lichtenstein, J. Lau, and A. G. Pittas
Effect of Chromium Supplementation on Glucose Metabolism and Lipids: A systematic review of randomized controlled trials
Diabetes Care,
August 1, 2007;
30(8):
2154 - 2163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kleefstra, S. T. Houweling, S. J.L. Bakker, S. Verhoeven, R. O.B. Gans, B. Meyboom-de Jong, and H. J.G. Bilo
Chromium Treatment Has No Effect in Patients With Type 2 Diabetes in a Western Population: A randomized, double-blind, placebo-controlled trial
Diabetes Care,
May 1, 2007;
30(5):
1092 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martin, Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes
Diabetes Care,
August 1, 2006;
29(8):
1826 - 1832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Cefalu and F. B. Hu
Role of Chromium in Human Health and in Diabetes
Diabetes Care,
November 1, 2004;
27(11):
2741 - 2751.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rajpathak, E. B. Rimm, T. Li, J. S. Morris, M. J. Stampfer, W. C. Willett, and F. B. Hu
Lower Toenail Chromium in Men With Diabetes and Cardiovascular Disease Compared With Healthy Men
Diabetes Care,
September 1, 2004;
27(9):
2211 - 2216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Frauchiger, C. Wenk, and P. C. Colombani
Effects of Acute Chromium Supplementation on Postprandial Metabolism in Healthy Young Men
J. Am. Coll. Nutr.,
August 1, 2004;
23(4):
351 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook
Chromium as Adjunctive Treatment for Type 2 Diabetes
Ann. Pharmacother.,
June 1, 2003;
37(6):
876 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D Althuis, N. E Jordan, E. A Ludington, and J. T Wittes
Glucose and insulin responses to dietary chromium supplements: a meta-analysis
Am. J. Clinical Nutrition,
July 1, 2002;
76(1):
148 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Edens, L. A. Reaves, M. S. Bergana, I. L. Reyzer, P. O'Mara, J. H. Baxter, and M. K. Snowden
Yeast Extract Stimulates Glucose Metabolism and Inhibits Lipolysis in Rat Adipocytes in Vitro
J. Nutr.,
June 1, 2002;
132(6):
1141 - 1148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E Gunton, G. Hams, R. Hitchman, and A. McElduff
Serum chromium does not predict glucose tolerance in late pregnancy
Am. J. Clinical Nutrition,
January 1, 2001;
73(1):
99 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Guan, J. J. Matte, P. K. Ku, J. L. Snow, J. L. Burton, and N. L. Trottier
High Chromium Yeast Supplementation Improves Glucose Tolerance in Pigs by Decreasing Hepatic Extraction of Insulin
J. Nutr.,
May 1, 2000;
130(5):
1274 - 1279.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. A. Anderson
Chromium, Glucose Intolerance and Diabetes
J. Am. Coll. Nutr.,
December 1, 1998;
17(6):
548 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W Mertz
The essential trace elements
Science,
September 18, 1981;
213(4514):
1332 - 1338.
[Abstract]
[PDF]
|
 |
|
Copyright © 1980 by the American Diabetes Association.
|
|
| |
|